Covered recipient · General Payments record
TINA XIA
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2019–2024
$3,273.36
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $654.00 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $234.16 | 2 |
| ABBVIE INC. | $214.53 | 9 |
| Sight Sciences, Inc. | $88.63 | 1 |
| Alcon Laboratories Inc | $42.65 | 2 |
| Thea Pharma Inc. | $36.49 | 2 |
| Bausch & Lomb Americas Inc. | $23.21 | 1 |
| Harrow Eye, LLC | $14.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.53 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106366426 | CMS |
| ABBVIE INC. | $31.28 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106366428 | CMS |
| ABBVIE INC. | $10.67 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106366430 | CMS |
| ABBVIE INC. | $16.49 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106366432 | CMS |
| ABBVIE INC. | $17.94 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106366434 | CMS |
| ABBVIE INC. | $87.50 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106366436 | CMS |
| ABBVIE INC. | $17.19 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106366438 | CMS |
| ABBVIE INC. | $12.43 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106366440 | CMS |
| ABBVIE INC. | $3.50 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106366442 | CMS |
| Alcon Vision LLC | $21.33 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110666995 | CMS |
| Alcon Vision LLC | $21.32 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110666993 | CMS |
| Bausch & Lomb Americas Inc. | $23.21 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140460846 | CMS |
| Glaukos Corporation | $97.36 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151986572 | CMS |
| Glaukos Corporation | $136.80 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151983162 | CMS |
| Harrow Eye, LLC | $14.33 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145622948 | CMS |
| Sight Sciences, Inc. | $88.63 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151931489 | CMS |
| Thea Pharma Inc. | $19.65 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074545815 | CMS |
| Thea Pharma Inc. | $16.84 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074545817 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.